All Medical News

• 

  All Medical News

  ILTS 2016: Hepatocellular Carcinoma: Size and number vs biology: Professor Rene Adam (Paul Brousse Hospital, France) gives the key messages from the debate.

  Written by Lorraine Carolan | 15 Jun 2016

• 

  All Medical News

  ILTS 2016: Hepatocellular Carcinoma: To resect or transplant first? Professor Rene Adam (Paul Brousse Hospital, France) gives the key messages from the debate.

  Written by Lorraine Carolan | 15 Jun 2016

• 

  All Medical News

  ILTS 2016 Report: Once-daily tacrolimus sees favourable results worldwide

  Written by Lorraine Carolan | 14 Jun 2016

  by Thomas R. Collins: Leading transplant experts say they’ve had a good experience using the once-a-day tacrolimus regimen, reporting better patient adherence compared to the twice-a-day version, along… read more.

• 

  All Medical News

  ILTS 2016: Risk of living donor transplants can be mitigated: Dr Leslie Lilly (Transplant Hepatologist, UHN Toronto General Hospital, ON, Canada). Also included associated article.

  Written by Lorraine Carolan | 13 Jun 2016

  Risk of living donor transplants can be mitigated by Thomas R. Collins Making living donor transplants less risky through new and innovative approaches is the best way to… read more.

• 

  All Medical News

  ILTS 2016: Professors John Lake (University of Minnesota, MN, USA) and John O’Grady (Kings College Hospital, London) discuss what’s novel in immuno-suppression. Also associated article included on Immunosuppression.

  Written by Lorraine Carolan | 13 Jun 2016

  Biomarkers emerging as guide on immunosuppression by Thomas R. Collins Using the right amount of immunosuppression treatment, but no more than necessary, is a challenge facing clinicians handling… read more.

• 

  All Medical News

  ILTS 2016: Professors John Lake (University of Minnesota, MN, USA) and John O’Grady (Kings College Hospital, London) discuss what's novel in immuno-suppression. Also associated article included on Immunosuppression.

  Written by Lorraine Carolan | 13 Jun 2016

  Biomarkers emerging as guide on immunosuppression by Thomas R. Collins Using the right amount of immunosuppression treatment, but no more than necessary, is a challenge facing clinicians handling… read more.

• 

  All Medical News

  ILTS 2016: Professor John O’Grady (Kings College Hospital, London) and Professor Sung-Gyu Lee (Ulsan University Medical School, Seoul, Korea) discuss their key messages in LDLT for the UK transplant community. Also included associated article entitled ‘Done correctly, living donation success is possible’

  Written by Lorraine Carolan | 10 Jun 2016

  Done correctly, living donation success is possible by Thomas R. Collins Life expectancy and quality of life measures tend to be quite high among live liver donors, generally… read more.

• 

  All Medical News

  ILTS 2016: Professor John O’Grady (Kings College Hospital, London) and Professor Sung-Gyu Lee (Ulsan University Medical School, Seoul, Korea) discuss their key messages in LDLT for the UK transplant community. Also included associated article entitled 'Done correctly, living donation success is possible'

  Written by Lorraine Carolan | 10 Jun 2016

  Done correctly, living donation success is possible by Thomas R. Collins Life expectancy and quality of life measures tend to be quite high among live liver donors, generally… read more.

• 

  All Medical News

  ILTS 2016 Highlights: ILTS President, Professor Jan Lerut (University Hospital St Luc, Brussels, Belgium), Professor Sung-Gyu Lee (Ulsan University Medical School, Seoul, Korea), Professor John Lake (University of Minnesota, MN, USA), Professor John O’Grady (Kings College Hospital, London) and Dr Leslie Lilly (Transplant Hepatologist, UHN Toronto General Hospital, ON, Canada) give their highlights from this year’s ILTS in Seoul.

  Written by Lorraine Carolan | 9 Jun 2016

• 

  All Medical News

  ISH/BSH 2016: DLBCL: controversies and global challenges

  Written by Christine Clark | 8 Jun 2016

  Dr Sridhar Chaganti, University Hospital, Birmingham NHS Foundation Trust, UK. by Christine Clark: In general the outcomes of treatment for diffuse large B-cell lymphoma (DLBCL) are good –… read more.

• 

  All Medical News

  ISH/BSH 2016: Changing treatment paradigms in multiple relapse HL

  Written by Christine Clark | 8 Jun 2016

  Professor Karl Peggs, University College, London. by Christine Clark: There are numerous regimens for salvage treatment of Hodgkin lymphoma and all are associated with an overall response rate… read more.

• 

  All Medical News

  ISH/BSH 2016: Professor John Radford (The University of Manchester) and Dr Graham Collins (Oxford University Hospitals) discuss the key issues to come out of the session on challenging current clinical practices in HL. Also included associated article entitled 'Rethinking risk for better outcomes in ASCT'

  Written by Christine Clark | 7 Jun 2016

  Rethinking risk for better outcomes in ASCT by Christine Clark Dr Craig Moskowitz, Memorial Sloan Kettering Cancer Center, NY, USA. Patient populations are changing – before 2010 all… read more.